Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials

Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial

(2012) Arthur Kavanaugh et al.   ARTHRITIS AND RHEUMATISM

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

(2012) Gabrielle H. Kingsley et al.   RHEUMATOLOGY

A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis

(2011) Zoe Ash et al.   ANNALS OF THE RHEUMATIC DISEASES

Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?

(2011) D. D. Gladman et al.   ANNALS OF THE RHEUMATIC DISEASES

A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study

(2010) K. Visser et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT

(2010) Dafna D Gladman et al.   ARTHRITIS RESEARCH & THERAPY

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

(2008) P J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES